IOF World Congress on Osteoporosis

Back to Homepage

Satellite Symposia
(updated 26.4.2002)

Thirteen cutting-edge satellite symposia will also be held during the IOF World Congress on Osteoporosis. Sponsored by 13 major pharmaceutical companies, the symposia will examine new diagnostic, and treatment options for osteoporosis and osteoarthritis.

Friday May 10, 2002
 
13:00 – 14:45 From Research to Clinical Evidence: Defining the Standard for Postmenopausal Women
Sponsor: Pfizer (Auditorium 1)
15:15 – 17:00 Optimizing Bone Formation and Resorption with Strontium Ranelate: An Innovative Therapeutic Approach to Osteoporosis
Sponsor: Servier (Auditorium 1)
17:15 – 19:00 Risedronate Therapy: Current Understandings, Clinical Applications and Future Directions
Sponsor: The Alliance for Better Bone Health (Aventis Pharma and Procter & Gamble Pharmaceuticals) (Auditorium 1)
19:15 – 20:45 The Role of HRT in Protecting Against Early Bone Loss
Sponsor: Wyeth-Ayerst (Auditorium 1)

Saturday May 11, 2002
 
15:30 – 17:15 Setting the Standard for Treating Osteoporosis: New Evidence for Optimal Patient Management
Sponsor: Merck, Sharpe & Dohme (Auditorium 1)
17:30 – 19:15 New Findings on the Effect of Alfacalcidol and D-Hormone Analogs on Fractures
Sponsor: Chugai Pharmaceutical Co., Teijin Ltd., and Teva Pharmaceutical Industries Ltd. (Hall 2)
19:45 – 21:30 BMD – Myth and Reality
Sponsor: Eli Lilly & Co. (Auditorium 1)

Sunday May 12, 2002
 
15:30 – 17:15 Achieving Balance – Encouraging Your Patients
Sponsor: Novartis (Auditorium 1)
17:30 – 19:15 New Options in the Treatment of Osteoporosis
Sponsors: Roche, GlaxoSmithKline (Auditorium 1)
19:30 – 21:15 Vitamin K and Osteoporosis
Sponsor: Eisai Co., Ltd., Japan (Auditorium 1)

Monday May 13, 2002
 
15:30 – 17:15 The Tissue Specific Approach to Osteoporosis
Sponsor: N.V. Organon (Auditorium 1)
17:30 – 19:15 Managing Osteoporosis: One Step Beyond
Sponsor: Eli Lilly & Co. (Auditorium 2)

Tuesday May 14, 2002
 
13:45 – 17:30 Recent Advances in Osteoarthritis (Auditorium 1)
17:45 – 19:45 Management of Pain With COX-2 Inhibition
Sponsor: Merck, Sharpe & Dohme (Auditorium 2)